Surmodics, Inc.
SRDX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $424,289 | $435,907 | $563,548 | $550,249 |
| - Cash | $26,281 | $29,183 | $30,145 | $36,115 |
| + Debt | $32,582 | $32,808 | $33,027 | $33,242 |
| Enterprise Value | $430,590 | $439,532 | $566,430 | $547,376 |
| Revenue | $29,567 | $28,085 | $29,922 | $33,227 |
| % Growth | 5.3% | -6.1% | -9.9% | – |
| Gross Profit | $20,991 | $20,255 | $22,497 | $24,553 |
| % Margin | 71% | 72.1% | 75.2% | 73.9% |
| EBITDA | -$5,242 | -$4,010 | $21 | $1,002 |
| % Margin | -17.7% | -14.3% | 0.1% | 3% |
| Net Income | -$5,318 | -$5,209 | -$3,651 | -$3,449 |
| % Margin | -18% | -18.5% | -12.2% | -10.4% |
| EPS Diluted | -0.37 | -0.36 | -0.26 | -0.24 |
| % Growth | -2.8% | -38.5% | -8.3% | – |
| Operating Cash Flow | $1,405 | $949 | -$7,894 | $3,658 |
| Capital Expenditures | -$501 | -$319 | -$302 | -$542 |
| Free Cash Flow | $904 | $630 | -$8,196 | $3,116 |